نتایج جستجو برای: rfsh

تعداد نتایج: 244  

Journal: :Fertility and sterility 2005
Franco Lisi Leonardo Rinaldi Simon Fishel Donatella Caserta Rosella Lisi Alison Campbell

OBJECTIVE To evaluate the efficacy of two doses of recombinant (r)LH, 75 IU (recommended) or 37.5 IU, for follicular stimulation and outcomes in a randomized cohort of IVF patients. DESIGN Randomized, prospective analysis. SETTING Private hospital incorporating an established IVF center. PATIENT(S) Women undergoing IVF who had a body mass index >18 or <35 and no abnormal karyotype, anovul...

Journal: :Human reproduction 2007
Susheel Vani Sarah E McDonald Alistair R W Williams J Ian Mason K Joo Thong Hilary O D Critchley

BACKGROUND There are concerns of reduced pregnancy rates with the use of gonadotrophin-releasing hormone antagonists (GnRH antagonists) in IVF/ICSI cycles. Sex steroids and their metabolizing enzymes in the endometrium may play a vital role in embryo implantation. This study has evaluated the levels and localization of sex-steroid receptors and metabolizing enzymes, 3beta-hydroxysteroid dehydro...

2016
Helmy Selman Leonardo Rinaldi

PURPOSE To evaluate the efficiency and efficacy of corifollitropin alfa (follicle-stimulating hormone-carboxy terminal peptide) in the treatment of poor responder patients. METHODS A total of 85 poor responder patients with a mean age 40.2±3.9 years entered our assisted fertilization program. The patients were prospectively randomized into two groups based on the ovarian stimulation regimen u...

2016
Leonardo Rinaldi Helmy Selman

A severe gonadotropin deficiency together with chronic estradiol deficiency leading to amenorrhea characterizes patients suffering from hypogonadotropic hypogonadism. Administration of both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to these patients has been shown to be essential in achieving successful stimulation of follicular development, ovulation, and rescue of fertil...

A Amiri Yekta B Abd Emami F Tabande M Gharanfoli M Qafary, MH Sanati N Fatemi SM Qafari

Background One of the common gonadotropin hormones used for infertility treatment is recombinant Follicle stimulating hormone (rFSH). pH is an environmental factor that can affect production of recombinant proteins with no imposing cost. Culture pH is known as a parameter that significantly affects cell growth and protein production. In this study, tried to investigate the effect of different p...

Alavy Toussy J Azargoon A, Bahrami M

Background: Different protocols are used for controlled ovarian hyper stimulation (COH), but the optimal method has not yet been determined. So we decided to compare the outcome of controlled ovarian stimulation using clomiphen citrate +HMG versus clomiphen citrate +rFSH in IUI cycles. Materials and Methods: 144 women with unexplained or male factor infertility undergoing IUI cycles (72 patient...

Journal: :Human reproduction 1998
I E Messinis S Milingos K Zikopoulos G Hasiotis K Seferiadis D Lolis

Oestradiol enhances pituitary sensitivity to gonadotrophin-releasing hormone (GnRH) in normal women, while in women undergoing ovulation induction the putative factor gonadotrophin surge attenuating factor (GnSAF) attenuates the response of luteinizing hormone (LH) to GnRH. To study the relationships between oestradiol and GnSAF during ovulation induction, 15 normally ovulating women were inves...

Journal: :Human Reproduction 2001

2015
Xuemei Liu Cuifang Hao Jinfang Wang

BACKGROUND Urine derived follicle-stimulating hormone (uFSH) contains a higher proportion of acidic isoforms, whereas recombinant FSH (rFSH) contains a higher proportion of less-acidic isoforms. Less-acidic isoforms have a faster clearance, and thus a shorter half-life than the acidic FSH isoforms. The slow clearance of the acidic isoforms has a longer half-life and higher biological activity. ...

Journal: :Human reproduction 2012
Maryse Bonduelle Bernadette Mannaerts Arthur Leader Christina Bergh Dorrie Passier Paul Devroey

STUDY QUESTION Is treatment with corifollitropin alfa, a new recombinant gonadotrophin with sustained follicle-stimulating activity, safe in terms of perinatal complications and birth defects in infants conceived following corifollitropin alfa treatment for contolled ovarian stimulation (COS)? SUMMARY ANSWER In terms of neonatal outcome and risk of malformations, treatment with a single dose ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید